Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.05
+0.51 (6.76%)
At close: Aug 13, 2025, 4:00 PM
8.05
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:39 PM EDT
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $433.33 million as of August 13, 2025. Its market cap has decreased by -67.01% in one year.
Market Cap
433.33M
Enterprise Value
64.68M
1-Year Change
-67.01%
Ranking
Category
Stock Price
$8.05
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $433.33M, an increase of 240.40%. That is a compound annual growth rate of 10.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 405.90M | -45.54% |
Dec 31, 2024 | 745.30M | -61.78% |
Dec 29, 2023 | 1.95B | -33.09% |
Dec 30, 2022 | 2.91B | 26.63% |
Dec 31, 2021 | 2.30B | 380.02% |
Dec 31, 2020 | 479.50M | -24.08% |
Dec 31, 2019 | 631.60M | 53.82% |
Dec 31, 2018 | 410.60M | -71.51% |
Dec 29, 2017 | 1.44B | -15.04% |
Dec 30, 2016 | 1.70B | -20.98% |
Dec 31, 2015 | 2.15B | 277.66% |
Dec 31, 2014 | 568.50M | -1.92% |
Dec 31, 2013 | 579.60M | 347.22% |
Dec 31, 2012 | 129.60M | 1.81% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 579.78B |
Johnson & Johnson | 418.35B |
AbbVie | 349.02B |
UnitedHealth Group | 231.76B |
Abbott Laboratories | 229.55B |
AstraZeneca | 227.85B |
Novartis AG | 225.61B |
Novo Nordisk | 224.34B |